Ablynx Announces Nanobody Drug Discovery Collaboration, Licence Agreement With Novo Nordisk
November 25, 2015 at 04:23 AM EST
Ablynx (OTC: ABYLY) today announced that it has entered into a global exclusive collaboration and licensing agreement with Novo Nordisk ...